GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vivesto AB (OTCPK:OASMY) » Definitions » Ending Cash Position

OASMY (Vivesto AB) Ending Cash Position : $0.07 Mil (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Vivesto AB Ending Cash Position?

Vivesto AB's Ending Cash Position for the quarter that ended in Dec. 2024 was $0.07 Mil.

Vivesto AB's quarterly Ending Cash Position declined from Jun. 2024 ($0.28 Mil) to Sep. 2024 ($0.16 Mil) and declined from Sep. 2024 ($0.16 Mil) to Dec. 2024 ($0.07 Mil).

Vivesto AB's annual Ending Cash Position declined from Dec. 2022 ($0.91 Mil) to Dec. 2023 ($0.42 Mil) and declined from Dec. 2023 ($0.42 Mil) to Dec. 2024 ($0.07 Mil).

Vivesto AB Ending Cash Position Historical Data

The historical data trend for Vivesto AB's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vivesto AB Ending Cash Position Chart

Vivesto AB Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Dec21 Dec22 Dec23 Dec24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.07 0.87 0.91 0.42 0.07

Vivesto AB Quarterly Data
Jan20 Apr20 Jul20 Oct20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.42 0.04 0.28 0.16 0.07

Vivesto AB Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Vivesto AB's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=0.391+-0.32
=0.07

Vivesto AB's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0.146+-0.075
=0.07

Vivesto AB Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Vivesto AB's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Vivesto AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vivesto AB (OTCPK:OASMY) » Definitions » Ending Cash Position
Comparable Companies
OSTO:ERMA OSTO:TOL OSTO:NANEXA XSAT:ACUC OSTO:NEWBRY OSTO:KLAR XSAT:ODI XSAT:PMED OSTO:GABA XSAT:DANCAN ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA
Traded in Other Exchanges
VIVE:Sweden
Address
Gustav III:s Boulevard 46, 5th Floor, Solna, SWE, SE-169 73
Website
https://www.vivesto.com
Vivesto AB is a research and development company that develops new treatment options for patients suffering from difficult-to-treat cancer. The company's product development leverages its proprietary technology platforms to manufacture novel drug formulations that are intended to demonstrate improved properties in comparison with current alternatives, which can lead to a reduced side-effect profile and an expanded therapeutic area. The company has a portfolio of projects targeting cancer treatments.